Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
In the OASIS 4 trial, adults taking the Wegovy pill at 25 mg lost an average of 13.6% of their body weight over 64 weeks, compared with 2.2% on placebo
Imagine the confidence boost that comes with knowing you are taking control of your health and future
Mixed reviews highlight the gap between promise and reality, making it a weak option for those seeking real GLP-1 treatment
Any reference to this compound is made in accordance with B2B and healthcare-facing guidelines
J.HalpinD.AnzuetoA.BarnesP.et al (2023)
This receptor profile distinguishes Triple G (Retatrutide 6 mg) from classical incretin agonists such as semaglutide and from molecules with a dual receptor profile such as tirzepatyd
US$ 25.29
US$ 26.41
US$ 27.44
US$ 28.23
